‘Challenges Ahead’ For Cell And Gene Therapy, Notes Catapult’s New Chairman McCubbin
The ex-GSK supply head Ian McCubbin will join the independent UK organization aimed at advancing cell and gene therapies, but notes issues with scale and manufacturing ahead.